Shelley B. Thunen, Chief Financial Officer at RxSight, Inc. (RXST), sold 40,000 shares at $39.32 ($1.6M) on 2023-12-15, disclosed to the SEC on 2023-12-18.
Scheduled sale ($1.6M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.31 | 10,000 | $393K | 25.0% |
| 2 | $39.32 | 10,000 | $393K | 25.0% |
| 3 | $39.35 | 20,000 | $787K | 50.0% |
| Total | $39.33 avg | 40,000 | $1.6M | 100% |
| Filing → |
| RXST | SELL | 2024-05-02 | $1.0M | — | Filing → |
| RXST | SELL | 2024-04-02 | $1.9M | — | Filing → |
| RXST | SELL | 2024-03-05 | $1.1M | — | Filing → |